SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹272 Cr | ₹277 Cr | ₹182 Cr | ₹140 Cr | ₹87 Cr |
What is the latest Total Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹272 Cr |
| Mar2024 | ₹277 Cr |
| Mar2023 | ₹182 Cr |
| Mar2022 | ₹140 Cr |
| Mar2017 | ₹87 Cr |
How is Total Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹272 Cr | -1.65 | |
| Mar2024 | ₹277 Cr | 52.47 | |
| Mar2023 | ₹182 Cr | 29.96 | |
| Mar2022 | ₹140 Cr | 61.55 | |
| Mar2017 | ₹87 Cr | - | |
Compare Total Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,409.1 Cr | -2.2% | -6.4% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,367.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -2.2% |
-6.4% |
-32.1% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses